Mike Magee

Vice President, US Quality Assurance

Mike Magee is responsible for quality assurance within Ferring US commercial operations, development and manufacturing.

Mike joined Ferring in 2015 from Discovery Laboratories, Inc. where he was Vice President, Technical Operations responsible for quality and manufacturing. Prior to that he spent 23 years with Johnson & Johnson in roles of increasing responsibility as he established his expertise in quality operations, manufacturing, and technical services for pharmaceutical and biopharmaceutical drug products.

Mike holds a Bachelor of Science degree in chemistry from Moravian College and a Bachelor of Science degree in pharmacy from Philadelphia College of Pharmacy and Science. He is a registered pharmacist in New Jersey.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2100028